Company Name Eisai Co., Ltd. Date Established December 6, 1941 Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan Telephone 81-3-3817-3700 Representatives Haruo Naito, President and CEO Soichi Matsuno, Deputy President Hideaki Matsui, Executive Vice President Makoto Shiina, Executive Vice President Nobuo Deguchi, Executive Vice President Capital 44,985 million Yen (as of March 31, 2009) Sales Consolidated : 781,743 million Yen Non-Consolidated : 415,611 million Yen (The year ended March 31, 2009) Scope of Business Manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs and Pharmaceuticals Production Systems and Equipment. Employees Consolidated : 10,977 Non-Consolidated : 4,308  (as of March 31, 2009) Communication Offices 67 Communication Offices in Japan  (as of March 31, 2009) Production Facilities Misato Plant (Saitama Prefecture) Kawashima Plant (Gifu Prefecture) Kashima Business Office (Ibaraki Prefectire) RTP Plant (NC, U.S.) Hatfield Factory (UK) Tainan Factory (Taiwan) Suzhou Factory (China) Bogor Factory (Indonesia), etc. R&D Facilities Tsukuba Research Laboratories (Ibaraki Prefecture) Kawashima Laboratory (Gifu Prefecture) KAN Research Institute Inc. (Hyogo Prefecture) Morphotek, Inc. (U.S.) Eisai Research Institute of Boston Inc. (U.S.) Eisai London Research Laboratories Ltd. (UK) Overseas Subsidiaries U.S., UK, Germany, France, Netherlands, Indonesia, Thailand, Taiwan, China, Korea, etc.